ICOSAVAX, INC. Financing Cash Flow
ICOSAVAX, INC. reported Financing Cash Flow of $67.98 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2023-11-14
- ICOSAVAX, INC. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was -$208.00K.
- ICOSAVAX, INC. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $68.07M, a 30425.11% increase year-over-year.
- ICOSAVAX, INC. net cash provided by (used in) financing activities for the quarter ending 2023-03-31 was $117.00K, a 57.61% decline year-over-year.
- ICOSAVAX, INC. net cash provided by (used in) financing activities for the quarter ending 2022-12-31 was $10.09M, a 3779.62% increase year-over-year.
- ICOSAVAX, INC. net cash provided by (used in) financing activities for fiscal 2022 was $10.31M, a 96.62% decline from fiscal 2021.
- ICOSAVAX, INC. net cash provided by (used in) financing activities for fiscal 2021 was $304.77M, a 4491.32% increase from fiscal 2020.
- ICOSAVAX, INC. net cash provided by (used in) financing activities for fiscal 2020 was $6.64M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$208.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $67.86M derived: sum of 2 quarters · filed 2023-11-14 | $67.98M 10-Q · filed 2023-11-14 | $78.07M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $68.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $68.19M 10-Q · filed 2023-08-14 | $78.28M derived: sum of 3 quarters · filed 2023-08-14 | $78.00M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | $117.00K 10-Q · filed 2023-05-10 | $10.20M derived: sum of 2 quarters · filed 2023-05-10 | $9.93M derived: sum of 3 quarters · filed 2023-11-14 | $10.15M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | $10.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $9.81M derived: sum of 2 quarters · filed 2023-11-14 | $10.03M derived: sum of 3 quarters · filed 2023-11-14 | $10.31M 10-K · filed 2023-03-30 |
| 2022-09-30 | -$279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$56.00K derived: sum of 2 quarters · filed 2023-11-14 | $220.00K 10-Q · filed 2023-11-14 | $480.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $499.00K 10-Q · filed 2023-08-14 | $759.00K derived: sum of 3 quarters · filed 2023-08-14 | $192.26M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $276.00K 10-Q · filed 2023-05-10 | $536.00K derived: sum of 2 quarters · filed 2023-05-10 | $192.04M derived: sum of 3 quarters · filed 2023-05-10 | $191.27M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $260.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $191.76M derived: sum of 2 quarters · filed 2023-03-30 | $190.99M derived: sum of 3 quarters · filed 2023-03-30 | $304.77M 10-K · filed 2023-03-30 |
| 2021-09-30 | $191.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $190.73M derived: sum of 2 quarters · filed 2022-11-14 | $304.51M 10-Q · filed 2022-11-14 | $306.22M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$767.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $113.01M 10-Q · filed 2022-08-15 | $114.72M derived: sum of 3 quarters · filed 2022-08-15 | $119.58M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $113.78M 10-Q · filed 2022-05-16 | $115.49M derived: sum of 2 quarters · filed 2022-05-16 | $120.35M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $6.57M derived: sum of 2 quarters · filed 2022-03-30 | $6.64M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $4.93M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $66.00K 10-Q · filed 2021-09-13 |